Novartis (NVS) stock news
Every headline mentioning Novartis from Yahoo Finance, Investing.com and CNBC over the last 30 days, each scored for sentiment and importance. Updated automatically through the trading day.
Headlines0last 7 days · 6 in 30 days
Sentiment, 30 days
0 positive0 neutral6 negative
Latest headlineThu 17 Sep, 15:21 UTCHealthcare
Latest NVS headlines
Thursday, 17 September 2026
Friday, 11 September 2026
Tuesday, 8 September 2026
European shares muted as oil rally fuels caution; Novartis tumbles
Pharma major Novartis falls 10% after three drug trial setbacks
Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.
Novartis’s failed trial for cholesterol drug leads to broad biopharma stock selloff
Along with several other drugmakers, Novartis has bet that lowering Lp(a) will cut the risk of sometimes fatal cardiovascular events.
Monday, 7 September 2026
Novartis Late-Stage Cardiovascular Outcome Study Fails, Stock Down
Novartis' pelacarsen study failed to cut cardiovascular events, clouding prospects for the drug and highlighting portfolio challenges.